Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's work developing brand-new antifungals has obtained a notable improvement co...

Capricor offers Europe legal rights to late-stage DMD treatment for $35M

.Having actually scooped up the USA civil rights to Capricor Therapies' late-stage Duchenne muscular...

FDA fragments adcomm for Applied's unusual disease medicine

.After pushing the choice date for Applied Therapies' metabolic ailment medication govorestat, the F...

Novo inks $600M NanoVation offer to examine hereditary medicines ex-liver

.Novo Nordisk is proceeding its press right into genetic medicines, agreeing to pay NanoVation Thera...

Innovent web links cytokine to colon cancer cells feedbacks

.Innovent Biologics has actually produced the situation that its gate inhibitor-cytokine combination...

Merck, Daiichi ADC hits objective in phase 3 bronchi cancer research

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina grows AI concentrate along with collab to choose cancer aim ats

.Five months after Rakovina Therapies rotated towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism drug hits in period 3, intimidates BioMarin

.Ascendis Pharma has emerged as a possible danger to BioMarin's Voxzogo, mentioning phase 3 developm...

Despite ph. 3 miss out on, Alkeus views path ahead for eye illness resource

.Though Alkeus Pharmaceuticals' oral eye disease resource fell short to considerably lessen geograph...

Kairos goes social with $6M IPO to money tests of cancer drug

.With a triad of biotechs attacking the Nasdaq on Friday, it was actually quick and easy to overlook...